Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Besifloxacin BID for Bacterial Conjunctivitis
NCT01740388Phase 3Terminated
- Sponsor
- Bausch + Lomb
- Start
- Feb 2013
- Primary completion
- Jul 2013
- Countries
- 1
01
Overview
A Phase 3 trial of Besifloxacin ophthalmic suspension vehicle in bacterial conjunctivitis (BC), sponsored by Bausch + Lomb. Started Feb 2013; status: terminated.
02
Drugs
Besifloxacin ophthalmic suspension vehicle
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT01740388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01740388.